Fortive — Jul 29, 2026 release

Financial Highlights for Second Quarter 2026 , Continuing Operations • Revenue of $1.10 billion, up 7.9% year-over-year; core revenue up 6.7% • GAAP net earnings of $157 million, up 40.9% year-over-year, GAAP net earnings margin of 14.3%; adjusted EBITDA of $323 million, up 12.0% year-over-year, adjusted EBITDA margin of 29.5% • GAAP diluted EPS of $0.51, up 54.5% year-over-year; adjusted diluted EPS of $0.74, up 28.5% year-over-year • GAAP operating cash flow of $299 million, Trailing Twelve Months (TTM) GAAP operating cash flow of $1,158M; free cash flow of $271 million, TTM free cash flow of $1,044M • Deployed ~$200 million towards share repurchases, representing ~3 million shares or ~1% of diluted shares outstanding Raising Full Year 2026 Guidance For FY 2026, Fortive now expects adjusted diluted earnings per share of $2.95 to $3.05. 1 Summary Financial Results , Continuing Operations Fortive Continuing Operations Q2-26 Q2-25 Variance Revenue $1,097M $1,016M 7.9% / 6.7% (reported / core) GAAP net earnings $157M $112M 40.9% GAAP net earnings margin 14.3% 11.0% 330 bps Adj. EBITDA $323M $288M 12.0% Adj. EBITDA margin 29.5% 28.4% 110 bps GAAP diluted earnings per share $0.51 $0.33 54.5% Adj. diluted earnings per share $0.74 $0.58 28.5% GAAP operating cash flow $299M $205M 45.7% Free cash flow $271M $180M 50.3% TTM GAAP operating cash flow $1,158M $1,029M 12.5% TTM free cash flow $1,044M $939M 11.2% Percentages presented may not recalculate based on the amounts shown due to rounding. Summary Financial Results by Segment , Continuing Operations Intelligent Operating Solutions Q2-26 Q2-25 Variance Revenue $758M $697M 8.8% / 7.4% (reported / core) GAAP operating profit $204M $171M 19.1% GAAP operating margin 26.8% 24.5% 230 bps Adj. EBITDA $264M $236M 12.2% Adj. EBITDA margin 34.9% 33.8% 110 bps Advanced Healthcare Solutions Q2-26 Q2-25 Variance Revenue $339M $320M 6.0% / 5.3% (reported / core) GAAP operating profit $38M $36M 7.0% GAAP operating margin 11.3% 11.2% 10 bps Adj. EBITDA $88M $86M 2.7% Adj. EBITDA margin